Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 179

1.

Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis.

Bernatsky S, Hudson M, Suissa S.

Rheumatology (Oxford). 2005 May;44(5):677-80. Epub 2005 Mar 22.

PMID:
15784627
[PubMed - indexed for MEDLINE]
Free Article
2.

Antirheumatic drug use and the risk of acute myocardial infarction.

Suissa S, Bernatsky S, Hudson M.

Arthritis Rheum. 2006 Aug 15;55(4):531-6.

PMID:
16874796
[PubMed - indexed for MEDLINE]
Free Article
3.

Newer disease-modifying antirheumatic drugs and the risk of serious hepatic adverse events in patients with rheumatoid arthritis.

Suissa S, Ernst P, Hudson M, Bitton A, Kezouh A.

Am J Med. 2004 Jul 15;117(2):87-92.

PMID:
15234643
[PubMed - indexed for MEDLINE]
4.

The risk of hospitalized infection in patients with rheumatoid arthritis.

Smitten AL, Choi HK, Hochberg MC, Suissa S, Simon TA, Testa MA, Chan KA.

J Rheumatol. 2008 Mar;35(3):387-93. Epub 2008 Feb 1.

PMID:
18260176
[PubMed - indexed for MEDLINE]
5.

Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis.

Bernatsky S, Hudson M, Suissa S.

Rheumatology (Oxford). 2007 Jul;46(7):1157-60. Epub 2007 May 3.

PMID:
17478469
[PubMed - indexed for MEDLINE]
Free Article
6.

Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.

Solomon DH, Avorn J, Katz JN, Weinblatt ME, Setoguchi S, Levin R, Schneeweiss S.

Arthritis Rheum. 2006 Dec;54(12):3790-8.

PMID:
17136752
[PubMed - indexed for MEDLINE]
Free Article
7.

Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis.

Suissa S, Hudson M, Ernst P.

Arthritis Rheum. 2006 May;54(5):1435-9.

PMID:
16645972
[PubMed - indexed for MEDLINE]
Free Article
8.

Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis.

Lacaille D, Guh DP, Abrahamowicz M, Anis AH, Esdaile JM.

Arthritis Rheum. 2008 Aug 15;59(8):1074-81. doi: 10.1002/art.23913.

PMID:
18668604
[PubMed - indexed for MEDLINE]
Free Article
9.

Risk of congestive heart failure with nonsteroidal antiinflammatory drugs and selective Cyclooxygenase 2 inhibitors: a class effect?

Hudson M, Rahme E, Richard H, Pilote L.

Arthritis Rheum. 2007 Apr 15;57(3):516-23.

PMID:
17394181
[PubMed - indexed for MEDLINE]
Free Article
10.

A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal.

Choy EH, Smith C, Doré CJ, Scott DL.

Rheumatology (Oxford). 2005 Nov;44(11):1414-21. Epub 2005 Jul 19. Review.

PMID:
16030080
[PubMed - indexed for MEDLINE]
Free Article
11.

Antirheumatic drugs and the risk of tuberculosis.

Brassard P, Kezouh A, Suissa S.

Clin Infect Dis. 2006 Sep 15;43(6):717-22. Epub 2006 Aug 10.

PMID:
16912945
[PubMed - indexed for MEDLINE]
Free Article
12.

Lung cancer after exposure to disease modifying anti-rheumatic drugs.

Bernatsky S, Clarke A, Suissa S.

Lung Cancer. 2008 Feb;59(2):266-9. Epub 2007 Jul 30.

PMID:
17673329
[PubMed - indexed for MEDLINE]
13.

The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years.

Nicola PJ, Maradit-Kremers H, Roger VL, Jacobsen SJ, Crowson CS, Ballman KV, Gabriel SE.

Arthritis Rheum. 2005 Feb;52(2):412-20.

PMID:
15692992
[PubMed - indexed for MEDLINE]
Free Article
14.

Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, Canada.

Brassard P, Lowe AM, Bernatsky S, Kezouh A, Suissa S.

Arthritis Rheum. 2009 Mar 15;61(3):300-4. doi: 10.1002/art.24476.

PMID:
19248128
[PubMed - indexed for MEDLINE]
Free Article
15.

Toward a definition and method of assessment of treatment failure and treatment effectiveness: the case of leflunomide versus methotrexate.

Wolfe F, Michaud K, Stephenson B, Doyle J.

J Rheumatol. 2003 Aug;30(8):1725-32.

PMID:
12913927
[PubMed - indexed for MEDLINE]
16.

Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.

Maradit-Kremers H, Nicola PJ, Crowson CS, O'Fallon WM, Gabriel SE.

J Rheumatol. 2006 Feb;33(2):248-55. Epub 2005 Dec 15.

PMID:
16358365
[PubMed - indexed for MEDLINE]
17.

Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study.

Nadareishvili Z, Michaud K, Hallenbeck JM, Wolfe F.

Arthritis Rheum. 2008 Aug 15;59(8):1090-6. doi: 10.1002/art.23935.

PMID:
18668583
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Tumor necrosis factor-α blockade, cardiovascular outcomes, and survival in rheumatoid arthritis.

Al-Aly Z, Pan H, Zeringue A, Xian H, McDonald JR, El-Achkar TM, Eisen S.

Transl Res. 2011 Jan;157(1):10-8. doi: 10.1016/j.trsl.2010.09.005. Epub 2010 Oct 21.

PMID:
21146146
[PubMed - indexed for MEDLINE]
19.

The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom.

Smitten AL, Choi HK, Hochberg MC, Suissa S, Simon TA, Testa MA, Chan KA.

Arthritis Rheum. 2007 Dec 15;57(8):1431-8.

PMID:
18050184
[PubMed - indexed for MEDLINE]
Free Article
20.

Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis.

Nicola PJ, Crowson CS, Maradit-Kremers H, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE.

Arthritis Rheum. 2006 Jan;54(1):60-7.

PMID:
16385496
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk